This study investigates pancreatic cancer. It looks at how Pancreatic Exocrine Replacement Therapy (PERT) works for patients who cannot have surgery.
The study evaluates how safe and effective PERT is when used with other treatments. It checks if PERT helps people with pancreatic cancer who have lost a lot of weight.
- Who can participate: Adults with pancreatic cancer that cannot be removed by surgery can join. Participants need to have lost at least 5% of their body weight and have a life expectancy of at least six months.
- Study details: Participants will receive either the best standard of care or the standard care plus PERT. PERT includes capsules taken with meals and snacks. A placebo is not used in this study.
- Study timelines: The study will last six months.